A citation-based method for searching scientific literature

Marco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, Maureen D Mayes, Vivien M Hsu, Patrick Carpentier, Fredrick M Wigley, Carol M Black, Barri J Fessler, Peter A Merkel, Janet E Pope, Nadera J Sweiss, Mittie K Doyle, Bernhard Hellmich, Thomas A Medsger, Adele Morganti, Fabrice Kramer, Joseph H Korn, James R Seibold. Ann Rheum Dis 2011
Times Cited: 277







List of co-cited articles
988 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
J H Korn, M Mayes, M Matucci Cerinic, M Rainisio, J Pope, E Hachulla, E Rich, P Carpentier, J Molitor, J R Seibold,[...]. Arthritis Rheum 2004
451
52

Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.
Eric Hachulla, Pierre-Yves Hatron, Patrick Carpentier, Christian Agard, Emmanuel Chatelus, Patrick Jego, Luc Mouthon, Viviane Queyrel, Anne-Laure Fauchais, Ulrique Michon-Pasturel,[...]. Ann Rheum Dis 2016
68
52

Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
439
36

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
Dinesh Khanna, Christopher P Denton, Peter A Merkel, Thomas Krieg, Franck-Olivier Le Brun, Angelina Marr, Kelly Papadakis, Janet Pope, Marco Matucci-Cerinic, Daniel E Furst. JAMA 2016
66
53

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
32

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.
F M Wigley, R A Wise, J R Seibold, D A McCloskey, G Kujala, T A Medsger, V D Steen, J Varga, S Jimenez, M Mayes,[...]. Ann Intern Med 1994
269
29

Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis.
Theresa Tingey, Jenny Shu, Joseph Smuczek, Janet Pope. Arthritis Care Res (Hoboken) 2013
70
32

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
E C LeRoy, C Black, R Fleischmajer, S Jablonska, T Krieg, T A Medsger, N Rowell, F Wollheim. J Rheumatol 1988
23

Digital ulcers: overt vascular disease in systemic sclerosis.
V Steen, C P Denton, J E Pope, M Matucci-Cerinic. Rheumatology (Oxford) 2009
139
20

Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.
Laura Amanzi, Francesca Braschi, Ginevra Fiori, Felice Galluccio, Irene Miniati, Serena Guiducci, Maria-Letizia Conforti, Olga Kaloudi, Francesca Nacci, Oana Sacu,[...]. Rheumatology (Oxford) 2010
120
19

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.
Michael Hughes, Voon H Ong, Marina E Anderson, Frances Hall, Pia Moinzadeh, Bridget Griffiths, Eileen Baildam, Christopher P Denton, Ariane L Herrick. Rheumatology (Oxford) 2015
70
27

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.
Eric Hachulla, Pierre Clerson, David Launay, Marc Lambert, Sandrine Morell-Dubois, Viviane Queyrel, Pierre-Yves Hatron. J Rheumatol 2007
140
19

Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry.
Marco Matucci-Cerinic, Thomas Krieg, Loic Guillevin, Barbara Schwierin, Daniel Rosenberg, Peter Cornelisse, Christopher P Denton. Ann Rheum Dis 2016
48
39

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
967
18

Digital ulcers predict a worse disease course in patients with systemic sclerosis.
Carina Mihai, Robert Landewé, Désirée van der Heijde, Ulrich A Walker, Paul I Constantin, Ana Maria Gherghe, Ruxandra Ionescu, Simona Rednic, Yannick Allanore, Jérôme Avouac,[...]. Ann Rheum Dis 2016
80
21

Ischemic digital ulcers affect hand disability and pain in systemic sclerosis.
Luc Mouthon, Patrick H Carpentier, Catherine Lok, Pierre Clerson, Virginie Gressin, Eric Hachulla, Alice Bérezné, Elisabeth Diot, Aurélie Khau Van Kien, Patrick Jego,[...]. J Rheumatol 2014
42
40

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
966
17

Systemic sclerosis.
Christopher P Denton, Dinesh Khanna. Lancet 2017
697
17

Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials.
Matthieu Roustit, Sophie Blaise, Yannick Allanore, Patrick H Carpentier, Evren Caglayan, Jean-Luc Cracowski. Ann Rheum Dis 2013
86
18

Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Sarit Khimdas, Sarah Harding, Ash Bonner, Brittany Zummer, Murray Baron, Janet Pope. Arthritis Care Res (Hoboken) 2011
86
17

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
Jacob M van Laar, Dominique Farge, Jacob K Sont, Kamran Naraghi, Zora Marjanovic, Jérôme Larghero, Annemie J Schuerwegh, Erik W A Marijt, Madelon C Vonk, Anton V Schattenberg,[...]. JAMA 2014
369
15

Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Tomás Pulido, Igor Adzerikho, Richard N Channick, Marion Delcroix, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Pavel Jansa, Zhi-Cheng Jing, Franck-Olivier Le Brun, Sanjay Mehta,[...]. N Engl J Med 2013
773
15

Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, Frédérique Dupuis-Siméon, Eric Hachulla, Pierre-Yves Hatron, Joël Constans, Daniéla Cirstéa, Dominique Farge-Bancel, Patrick H Carpentier. J Rheumatol 2009
65
21

Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis.
Murray Baron, Lorinda Chung, Geneviève Gyger, Laura Hummers, Dinesh Khanna, Maureen D Mayes, Janet E Pope, Ami A Shah, Virginia D Steen, Russell Steele,[...]. Clin Rheumatol 2014
37
37


2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Ann Rheum Dis 2013
995
14

Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers.
A Bérezné, R Seror, S Morell-Dubois, M de Menthon, E Fois, A Dzeing-Ella, C Nguyen, E Hachulla, L Guillevin, S Poiraudeau,[...]. Arthritis Care Res (Hoboken) 2011
71
19

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Lancet 2016
319
14

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
F M Wigley, J R Seibold, R A Wise, D A McCloskey, W P Dole. J Rheumatol 1992
141
13

Bosentan therapy for pulmonary arterial hypertension.
Lewis J Rubin, David B Badesch, Robyn J Barst, Nazzareno Galie, Carol M Black, Anne Keogh, Tomas Pulido, Adaani Frost, Sebastien Roux, Isabelle Leconte,[...]. N Engl J Med 2002
13

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Peter A Merkel, Karen Herlyn, Richard W Martin, Jennifer J Anderson, Maureen D Mayes, Patrice Bell, Joseph H Korn, Robert W Simms, Mary Ellen Csuka, Thomas A Medsger,[...]. Arthritis Rheum 2002
228
13

Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis.
Ariane L Herrick, Frank van den Hoogen, Armando Gabrielli, Nihad Tamimi, Carol Reid, Damian O'Connell, Maria-Dolores Vázquez-Abad, Christopher P Denton. Arthritis Rheum 2011
67
19

Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial.
Padmanabha D Shenoy, Sudeep Kumar, Lalan K Jha, Sunil K Choudhary, Uttam Singh, Ramnath Misra, Vikas Agarwal. Rheumatology (Oxford) 2010
93
13

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
442
13

Digital ulcers in systemic sclerosis.
Michael Hughes, Ariane L Herrick. Rheumatology (Oxford) 2017
77
16

Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors.
C Sunderkötter, I Herrgott, C Brückner, P Moinzadeh, C Pfeiffer, J Gerss, N Hunzelmann, M Böhm, T Krieg, U Müller-Ladner,[...]. Br J Dermatol 2009
79
15


Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
D B Badesch, V F Tapson, M D McGoon, B H Brundage, L J Rubin, F M Wigley, S Rich, R J Barst, P S Barrett, K M Kral,[...]. Ann Intern Med 2000
756
12

Review: evidence that systemic sclerosis is a vascular disease.
Marco Matucci-Cerinic, Bashar Kahaleh, Fredrick M Wigley. Arthritis Rheum 2013
241
12

A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact.
H Ennis, A Vail, E Wragg, A Taylor, T Moore, A Murray, L Muir, C E M Griffiths, A L Herrick. Scand J Rheumatol 2013
36
33

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
O Kowal-Bielecka, R Landewé, J Avouac, S Chwiesko, I Miniati, L Czirjak, P Clements, C Denton, D Farge, K Fligelstone,[...]. Ann Rheum Dis 2009
358
12

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.
Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, Friedrich Grimminger, Jian-Guo He, Gabriela Riemekasten, Carmine Dario Vizza, Annette Boeckenhoff, Christian Meier, Janethe de Oliveira Pena,[...]. Ann Rheum Dis 2017
63
19

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, Peter A McSweeney, Ashley Pinckney, Beverly Welch, Maureen D Mayes, Richard A Nash, Leslie J Crofford, Barry Eggleston,[...]. N Engl J Med 2018
228
12

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Martial Koenig, France Joyal, Marvin J Fritzler, André Roussin, Michal Abrahamowicz, Gilles Boire, Jean-Richard Goulet, Eric Rich, Tamara Grodzicky, Yves Raymond,[...]. Arthritis Rheum 2008
341
11


Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
B Coleiro, S E Marshall, C P Denton, K Howell, A Blann, K I Welsh, C M Black. Rheumatology (Oxford) 2001
141
11

BSR and BHPR guideline for the treatment of systemic sclerosis.
Christopher P Denton, Michael Hughes, Nataliya Gak, Josephine Vila, Maya H Buch, Kuntal Chakravarty, Kim Fligelstone, Luke L Gompels, Bridget Griffiths, Ariane L Herrick,[...]. Rheumatology (Oxford) 2016
77
14

Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.
Y A Suliman, C Bruni, S R Johnson, E Praino, M Alemam, N Borazan, L Cometi, B Meyers, D Khanna, Y Allanore,[...]. J Scleroderma Relat Disord 2017
41
26

Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate.
M Hughes, T Moore, J Manning, J Wilkinson, G Dinsdale, C Roberts, A Murray, A L Herrick. Microvasc Res 2017
21
52

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Ricardo J Bello, Carisa M Cooney, Eitan Melamed, Keith Follmar, Gayane Yenokyan, Gwendolyn Leatherman, Ami A Shah, Fredrick M Wigley, Laura K Hummers, Scott D Lifchez. Arthritis Rheumatol 2017
43
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.